Hepatocytes proteomic alteration and seroproteome analysis of HBV-transgenic mice

Proteomics

Volumn 9, Issue 1, 2009, Pages 87-105

  Ding, Chen ^a   Wei, Haiming ^a   Sun, Rui ^a   Zhang, Jian ^b   Tian, Zhigang ^a,b,c  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b SHANDONG UNIVERSITY   (China)

^c UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

Hepatitis B virus; Patients; Seroproteome analysis; Transgenic mice

Indexed keywords

ADENOSINE TRIPHOSPHATE; HYDROGEN PEROXIDE; REACTIVE OXYGEN METABOLITE; AUTOANTIBODY; COLLAGEN; PROTEOME;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CITRIC ACID CYCLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE; GPX GENE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; LIVER; LIVER CELL; LIVER DISEASE; LIVER MITOCHONDRION; MASS SPECTROMETRY; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OGG GENE; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; SERUM; SOD GENE; TRANSGENIC MOUSE; TWO DIMENSIONAL ELECTROPHORESIS; UPREGULATION; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; BLOOD; CHEMISTRY; GENE EXPRESSION REGULATION; IMMUNOLOGY; METABOLISM; MITOCHONDRION; MOLECULAR GENETICS; OXIDATION REDUCTION REACTION; PATHOLOGY; PHYSIOLOGY; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS; VIROLOGY;

HEPATITIS B VIRUS; MAMMALIA; MUS; MUS MUSCULUS;

AMINO ACID SEQUENCE; ANIMALS; AUTOANTIBODIES; CELL DEATH; CHROMATOGRAPHY, LIQUID; COLLAGEN; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GENE EXPRESSION REGULATION; HEPATITIS B; HEPATITIS B VIRUS; HEPATOCYTES; HUMANS; HYDROGEN PEROXIDE; LIVER; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; MITOCHONDRIA; MOLECULAR SEQUENCE DATA; OXIDATION-REDUCTION; PROTEOME; REACTIVE OXYGEN SPECIES; TANDEM MASS SPECTROMETRY;

EID: 59449083021     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200701053     Document Type: Article

References (39)

1. Lee, W. M., Hepatitis B virus infection. N. Engl. J. Med. 1997, 337, 1733-1745.
2. Chen, Y., Wei, H.,Gao, B., Hu, Z., Zheng, S.,Tian, Z., Activation and function of hepatic NK cells in hepatitis B infection: an underinvestigated innate immune response. J. Viral Hepat. 2005, 12, 38-45.
3. Dong, Z., Zhang, J., Sun, R., Wei, H., Tian, Z., Impairment of liver regeneration correlates with activated hepatic NKT cells in HBV transgenic mice. Hepatology 2007, 45, 1400-1412.
4. Chen, Y., Wei, H., Sun, R., Dong, Z. et al., Increased susceptibility to liver injury in hepatitis B virus transgenic mice involves NKG2D-ligand interaction and natural killer cells. Hepatology 2007.
5. Chen, Y. Y., Cheng, M., Tian, Z. G., Hepatitis B virus down- regulates expressions of MHC class I molecules on hepatoplastoma cell line. Cell. Mol. Immunol. 2006, 3, 373-378.
6. Chen, Y., Sun, R., Jiang, W., Wei, H., Tian, Z., Liver-specific HBsAg transgenic mice are over-sensitive to Poly(I:C)- induced liver injury in NK cell- and IFN-gamma-dependent manner. J. Hepatol. 2007, 47, 183-190.
7. Chen, Y., Wei, H., Sun, R., Tian, Z., Impaired function of hepatic natural killer cells from murine chronic HBsAg carriers. Int. Immunopharmacol. 2005, 5, 1839-1852.
8. Foo, N. C., Ahn, B. Y., Ma, X., Hyun, W., Yen, T. S., Cellular vacuolization and apoptosis induced by hepatitis B virus large surface protein. Hepatology 2002, 36, 1400-1407.
9. Douette, P., Navet, R., Gerkens, P., de Pauw, E. et al., Steatosis-induced proteomic changes in liver mitochondria evidenced by two-dimensional differential in-gel electrophoresis. J. Proteome Res. 2005, 4, 2024-2031.
10. Venkatraman, A., Landar, A., Davis, A. J., Chamlee, L. et al., Modification of the mitochondrial proteome in response to the stress of ethanol-dependent hepatotoxicity. J. Biol. Chem. 2004, 279, 22092-22101.
11. Chignard, N., Shang, S., Wang, H., Marrero, J. et al., Cleavage of endoplasmic reticulum proteins in hepatocellular carcinoma: Detection of generated fragments in patient sera. Gastroenterology 2006, 130, 2010-2022.
12. Hanash, S., Disease proteomics. Nature 2003, 422, 226-232.
13. Zeindl-Eberhart, E., Haraida, S., Liebmann, S., Jungblut, P. R. et al., Detection and identification of tumor-associated protein variants in human hepatocellular carcinomas. Hepatology 2004, 39, 540-549.
14. Diamond, D. L., Proll, S. C., Jacobs, J. M., Chan, E. Y. et al., HepatoProteomics: applying proteomic technologies to the study of liver function and disease. Hepatology 2006, 44, 299-308.
15. Cui, F., Wang, Y., Wang, J., Wei, K. et al., The up-regulation of proteasome subunits and lysosomal proteases in hepato- cellular carcinomas of the HBx gene knockin transgenic mice. Proteomics 2006, 6, 498-504.
16. Blanc, J. F., Lalanne, C., Plomion, C., Schmitter, J. M. et al., Proteomic analysis of differentially expressed proteins in hepatocellular carcinoma developed in patients with chronic viral hepatitis C. Proteomics 2005, 5, 3778-3789.
17. Baranova, A., Liotta, L., Petricoin, E., Younossi, Z. M., The Role of genomics and proteomics: Technologies in studying non-alcoholic fatty liver disease. Clin. Liver Dis. 2007, 11, 209-220.
18. Li, X., Yang, X., Li, L., Liu, H., Liu, J., A truncated C-terminal fragment of Mycobacterium tuberculosis HSP70 gene enhanced potency of HBV DNA vaccine. Vaccine 2006, 24, 3321-3331.
19. Gao, L. F., Sun, W. S., Ma, C. H., Liu, S. X. et al., Establishment of mice model with human viral hepatitis B. World J. Gastroenterol. 2004, 10, 841-846.
20. Kristensen, D. B., Kawada, N., Imamura, K., Miyamoto, Y. et al., Proteome analysis of rat hepatic stellate cells. Hepatology 2000, 32, 268-277.
21. Wasinger, V. C., Cordwell, S. J., Cerpa-Poljak, A., Yan, J. X. et al., Progress with gene-product mapping of the Mollicutes: Mycoplasma genitalium. Electrophoresis 1995, 16, 1090-1094.
22. Parent, R., Beretta, L., Proteomics in the study of liver pathology. J. Hepatol. 2005, 43, 177-183.
23. Spreafico, A., Frediani, B., Capperucci, C., Chellini, F. et al., A proteomic study on human osteoblastic cells proliferation and differentiation. Proteomics 2006, 6, 3520-3532.
24. Paoletti, A. C., Parmely, T. J., Tomomori-Sato, C., Sato, S. et al., Quantitative proteomic analysis of distinct mammalian Mediator complexes using normalized spectral abundance factors. Proc. Natl. Acad. Sci. USA2006.
25. Yang, F., Yan, S., He, Y., Wang, F. et al., Expression of hepatitis B virus proteins in transgenic mice alters lipid metabolism and induces oxidative stress in the liver. J. Hepatol. 2008, 48, 12-19.
26. Zhao, C., Fang, C. Y., Tian, X. C., Wang, L. et al., Proteomic analysis of hepatitis B surface antigen positive transgenic mouse liver and decrease of cyclophilin A. J. Med. Virol. 2007, 79, 1478-1484.
27. Malhi, H., Gores, G. J., Lemasters, J. J., Apoptosis and necrosis in the liver: a tale of two deaths? Hepatology 2006, 43, S31-44.
28. Kass, G. E., Mitochondrial involvement in drug-induced hepatic injury. Chem. Biol. Interact. 2006, 163, 145-159.
29. Severi, T., Ying, C., Vermeesch, J. R., Cassiman, D. et al., Hepatitis B virus replication causes oxidative stress in HepAD38 liver cells. Mol. Cell. Biochem. 2006, 290, 79-85.
30. Hsieh, Y. H., Su, I. J., Wang, H. C., Chang, W. W. et al., Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage. Carcinogenesis 2004, 25, 2023-2032.
31. Yamaguchi, M., Role of calcium-binding protein regucalcin in regenerating rat liver. J. Gastroenterol. Hepatol. 1998, 13 Suppl, S106-S112.
32. Yamaguchi, M., The role of regucalcin in nuclear regulation of regenerating liver. Biochem. Biophys. Res. Commun. 2000, 276, 1-6.
33. Jung, M. C., Pape, G. R., Immunology of hepatitis B infection. Lancet Infect. Dis. 2002, 2, 43-50.
34. Chisari, F. V., Ferrari, C., Hepatitis B virus immunopathogenesis. Annu. Rev. Immunol. 1995, 13, 29-60.
35. Le Naour, F., Brichory, F., Misek, D. E., Brechot, C. et al.,A distinct repertoire of autoantibodies in hepatocellular carcinoma identified by proteomic analysis. Mol. Cell. Proteomics 2002, 1, 197-203.
36. Nardiello, S., Pizzella, T., Ronga, C., Galanti, B., Levels of anti-albumin autoantibodies in acute and chronic hepatitis B virus infection. Hepatogastroenterology 1990, 37 Suppl 2, 156-159.
37. Roozendaal, C., Zhao, M. H., Horst, G., Lockwood, C. M. et al., Catalase and alpha-enolase: two novel granulocyte autoantigens in inflammatory bowel disease (IBD). Clin. Exp. Immunol. 1998, 112, 10-16.
38. Orth, T., Kellner, R., Diekmann, O., Faust, J. et al., Identification and characterization of autoantibodies against catalase and alpha-enolase in patients with primary sclerosing cholangitis. Clin. Exp. Immunol. 1998, 112, 507-515.
39. Takashima, M., Kuramitsu, Y., Yokoyama, Y., Iizuka, N. et al., Proteomic analysis of autoantibodies in patients with hepatocellular carcinoma. Proteomics 2006, 6, 3894-3900.